Altre lingue Bionime Corporation

Azioni

4737

TW0004737002

Prezzo di chiusura Taiwan S.E. Altri mercati azionari 00:00:00 02/07/2024			Variaz. 5gg	Var. 1 gen.
69 ^TWD	0,00%		-1,57%	-7,75%

10/05	Bionime Corporation riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
15/03	Bionime Corporation riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05
Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	15/03
Bionime Corporation Announces Dividend for the Year Ended December 31, 2023	14/03
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11
Bionime Corporation Announces TFDA Approval for iFree Continuous Glucose Monitoring System Second-Class Medical Device License	13/10/23
Bionime Corporation Announces Resignation of Marvin Wu as Globle Sales Division Officer	18/08/23
Bionime Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Bionime Corporation Announces Appointment of Aling Lai as New Member to the Remuneration Committee	09/08/23
Bionime Corporation Appoints Aling Lai as Additional Member of Audit Committee	30/06/23
Bionime Corporation Approves Cash Dividends, Payable on August 18, 2023	30/06/23
Bionime Corporation Announces Election of Aling Lai as an Additional Independent Director	30/06/23
Bionime Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Bionime Corporation Revises Cash Dividend for 2022	10/05/23
Bionime Corporation Appoints Chen Hui-Zhen as Corporate Governance Officer	10/05/23
Bionime Corporation Announces Cash Dividend for 2022	14/03/23
Bionime Corporation Announces Resignation of Tai,Tsung-Kai as Institutional Director, Effective April 30, 2023	03/03/23
Bionime Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/11/22
Bionime Corporation Approves the Factory Area to Expand Building the Clean Room to Accommodate Production Equipment and Increase Production Capacity	09/11/22
Bionime Announces the Introduction of Its Revolutionary iFree CGM for Diabetes Management Coming Soon	02/11/22
Bionime Corporation to Launch the Rightest iFree CGM, Proposed to Offer Precise and Accurate Blood Glucose Measurement and Monitoring	01/11/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Bionime Corporation

Azioni

4737

TW0004737002

Altre lingue

Filtri